Art of performing dermoscopy during the times of coronavirus disease (COVID‐19): simple change in approach can save the day!

Dermatoscope is a convenient diagnostic tool used by dermatologists in the diagnosis of skin, hair and nail disorders. During dermoscopy, a dermatoscope comes in contact with the patient and hence can act as a potential source of nosocomial spread of infections.1 The uncertainty associated with the mode of spread of current coronavirus disease (COVID-19) has only lead to confusion and studies are underway to determine the role of zoonotic and environmental factors.2-4 There are reports of presence of severe acute respiratory syndrome coronavirus (SARS-CoV-2) on door handles, mobile phones and other surfaces.

[1]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[2]  M. Worm,et al.  Recurrent eczema herpeticum – a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  L. Skov,et al.  Prevalence of comorbidity and associated risk factors in adults with atopic dermatitis , 2017, Allergy.

[4]  H. Ko,et al.  Prevention of possible cross-infection among patients by dermoscopy: a brief review of the literature and our suggestion , 2013, Dermatology practical & conceptual.

[5]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[6]  H. Simon,et al.  Atopic Dermatitis: Collegium Internationale Allergologicum (CIA) Update 2019 , 2019, International Archives of Allergy and Immunology.

[7]  Min Kang,et al.  SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.

[8]  D. Cucinotta,et al.  WHO Declares COVID-19 a Pandemic , 2020, Acta bio-medica : Atenei Parmensis.

[9]  G. Kampf,et al.  Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents , 2020, Journal of Hospital Infection.

[10]  S. Recalcati.  Cutaneous manifestations in COVID‐19: a first perspective , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  J. Ring,et al.  ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[12]  C. Akdis,et al.  Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.

[13]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[14]  Zuowei Ni,et al.  Uncertainties about the transmission routes of 2019 novel coronavirus , 2020, Influenza and other respiratory viruses.

[15]  A. Muraro,et al.  Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  J. Ring,et al.  Quality of care in atopic dermatitis – a position statement by the European Task Force on Atopic Dermatitis (ETFAD) , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  Dylan H. Morris,et al.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 , 2020, The New England journal of medicine.

[18]  O. Guntinas-Lichius,et al.  [The Covid-19 pandemic and otolaryngology: What it comes down to?] , 2020, Laryngo- rhino- otologie.

[19]  Chander Grover,et al.  Innovative modification of the USB dermatoscope for mucoscopy. , 2017, Journal of the American Academy of Dermatology.